Search results :

Finasteride

More information: STITCH, PubChem (stereo-specific compound: 1) and possibly Wikipedia

ATC Codes: D11AX10, G04CB01

Side effects

Options: Hide MedDRA Preferred Terms ,   display only 20 labels

MedDRA Preferred Term Side effect Data for drug Placebo Labels
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38
Infection Infection 14.7% 15.5% x
Orthostatic hypotension Orthostatic hypotension 9.1% - 16.7% 8% x x x x x x x x x x x x x x x x x
Dizziness Dizziness 7.4% - 17.7% 8.1% x x x x x x x x x x x x x x x x x
Asthenia Asthenia 5.3% - 15.7% 7.1% x x x x x x x x x x x x x x x x x
Influenza Influenza 7.41% 7.71% x
Ejaculation disorder Abnormal ejaculation 4.5% - 7.2% 2.3% x x x x x x x x x x x x x x x x x
Ejaculation disorder postmarketing, 0.2% - 1.2% 0.1% - 0.7% x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x
Erectile dysfunction Erectile dysfunction postmarketing, 1.3% - 18.5% 0.7% - 12.2% x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x
Pharyngitis Pharyngitis 4.76% 3.64% x
Sinusitis Sinusitis 3.81% 2.78% x
Bronchitis Bronchitis 2.75% 2.25% x
Somnolence Somnolence 1.7% - 3.7% 1.5% x x x x x x x x x x x x x x x x x
Libido decreased Libido decreased postmarketing, 1.8% - 10% 1.3% - 5.7% x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x
Disturbance in sexual arousal Libido decreased postmarketing, 1.8% - 10% 1.3% - 5.7% x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x
Pain Pain 2.54% 2.46% x
Hypotension Hypotension 1.2% - 3.4% 0.7% x x x x x x x x x x x x x x x x x
Headache Headache 2% - 12.1% 2.3% - 10.3% x x x x x x x x x x x x x x x x x
Oedema peripheral Oedema peripheral 1.3% - 2.6% 0.9% x x x x x x x x x x x x x x x x x
Injury Trauma 1.8% 2.25% x
Gynaecomastia Gynaecomastia 1.1% - 2.2% 0.7% x x x x x x x x x x x x x x x x x
Dyspnoea Dyspnoea 0.7% - 2.1% 0.7% x x x x x x x x x x x x x x x x x
Rhinitis Rhinitis 1% - 1.3% 0.5% x x x x x x x x x x x x x x x x x
Breast enlargement Breast enlargement 0.5% - 1.8% 0.1% - 1.1% x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x
Dermatitis Rash postmarketing, 0.5% 0.1% - 0.2% x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x
Rash Rash postmarketing, 0.5% 0.1% - 0.2% x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x
Breast tenderness Breast tenderness postmarketing, 0.4% - 0.7% 0.1% - 0.3% x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x
Angioedema Angioedema postmarketing x x x x x x x x x
Mental disorder Mental disorder postmarketing x x x x x x x
Breast disorder Breast disorder postmarketing x x x x x x x x x x x x x x
Hypersensitivity Hypersensitivity postmarketing x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x
Immune system disorder Immune system disorder postmarketing x x x x x x x
Infertility male Infertility male postmarketing x x x x x x x x x x x x x x x x x x x x x x x x x x x
Neoplasm Neoplasm postmarketing x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x
Orgasm abnormal Orgasm abnormal postmarketing x x x x x x x x x x x x x x x x
Pruritus Pruritus postmarketing x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x
Swelling Swelling postmarketing x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x
Testicular pain Testicular pain postmarketing x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x
Urticaria Urticaria postmarketing x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x
Androgenetic alopecia Androgenetic alopecia postmarketing x x x x x x x x x
Breast cancer male Breast cancer male postmarketing x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x
Sexual dysfunction Sexual dysfunction postmarketing, 2% - 2.5% 0.9% x x x x x x x x x x x x x x x x x x x x x x x x x x x x
Breast cancer Breast cancer x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x
Neoplasm malignant Neoplasm malignant x
Musculoskeletal disorder Musculoskeletal disorder x
Prostatic disorder Prostatic disorder x x
Neoplasm prostate Neoplasm prostate x
Prostatic specific antigen increased Prostatic specific antigen increased x x x x x x x x x x x x x x x x x x x x x x x x
Tenderness Tenderness x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

finasteride / Propecia

Side effects:10
Source:FDA

FINASTERIDE / PROSCAR

Side effects:13
Source:FDA

FINASTERIDE

Side effects:13
Source:FDA Structured Product Label

FINASTERIDE / PROPECIA

Side effects:13
Source:FDA

FINASTERIDE

Side effects:14
Source:FDA Structured Product Label

FINASTERIDE

Side effects:14
Source:FDA Structured Product Label

FINASTERIDE

Side effects:15
Source:FDA Structured Product Label

Finasteride tablets / Fintral, Tablet

Side effects:15
Source:Medsafe

finasteride / Propecia, Film coated tablet

Side effects:18
Source:Medsafe

FINASTERIDE

Side effects:19
Source:FDA Structured Product Label

FINASTERIDE

Side effects:19
Source:FDA Structured Product Label

Finasteride

Side effects:19
Source:FDA Structured Product Label

FINASTERIDE

Side effects:20
Source:FDA Structured Product Label

FINASTERIDE

Side effects:20
Source:FDA Structured Product Label

FINASTERIDE

Side effects:20
Source:FDA Structured Product Label

FINASTERIDE

Side effects:20
Source:FDA Structured Product Label

finasteride / FINASTERIDE ALPHAPHARM

Side effects:18
Source:medicines.org.au

finasteride / Proscar, Film coated tablet

Side effects:19
Source:Medsafe

PROSCAR / Tablets

Side effects:20
Source:medicines.org.au

(finasteride) Tablets / PROPECIA

Side effects:28
Source:medicines.org.au

FINASTERIDE / PROSCAR

Side effects:25
Source:Health Canada

finasteride / Proscar

Side effects:24
Source:FDA

FINASTERIDE / PROSCAR

Side effects:25
Source:FDA

FINASTERIDE

Side effects:27
Source:FDA Structured Product Label

FINASTERIDE

Side effects:28
Source:FDA Structured Product Label

FINASTERIDE

Side effects:28
Source:FDA Structured Product Label

FINASTERIDE

Side effects:28
Source:FDA Structured Product Label

finasteride

Side effects:28
Source:FDA Structured Product Label

FINASTERIDE

Side effects:29
Source:FDA Structured Product Label

FINASTERIDE

Side effects:30
Source:FDA Structured Product Label

FINASTERIDE

Side effects:30
Source:FDA Structured Product Label

FINASTERIDE

Side effects:30
Source:FDA Structured Product Label

FINASTERIDE

Side effects:30
Source:FDA Structured Product Label

FINASTERIDE

Side effects:31
Source:FDA Structured Product Label

FINASTERIDE

Side effects:31
Source:FDA Structured Product Label

FINASTERIDE

Side effects:31
Source:FDA Structured Product Label

FINASTERIDE

Side effects:31
Source:FDA Structured Product Label

Color scheme:

standard – alternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label